Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis-Reference-Cited by-同舟云学术

Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis

Published:2022-06 Issue:6 Volume:3 Page:e381-e393
ISSN:2666-7568
Container-title:The Lancet Healthy Longevity
language:en
Short-container-title:The Lancet Healthy Longevity

Author:

Hudson Jemma,Cruickshank Moira,Quinton Richard,Aucott Lorna,Aceves-Martins Magaly,Gillies Katie,Bhasin Shalender,Snyder Peter J,Ellenberg Susan S,Grossmann Mathis,Travison Thomas G,Gianatti Emily J,van der Schouw Yvonne T,Emmelot-Vonk Marielle H,Giltay Erik J,Hackett Geoff,Ramachandran Sudarshan,Svartberg Johan,Hildreth Kerry L,Groti Antonic Kristina,Brock Gerald B,Tenover J Lisa,Tan Hui Meng,Kong Christopher Ho Chee,Tan Wei Shen,Marks Leonard S,Ross Richard J,Schwartz Robert S,Manson Paul,Roberts Stephen,Andersen Marianne Skovsager,Magnussen Line Velling,Hernández Rodolfo,Oliver Nick,Wu Frederick,Dhillo Waljit S,Bhattacharya Siladitya,Brazzelli Miriam,Jayasena Channa N

Publisher

Elsevier BV

Subject

Family Practice,Psychiatry and Mental health,Geriatrics and Gerontology,Health (social science)

Reference68 articles.

1. Global trends in testosterone prescribing, 2000–2011: expanding the spectrum of prescription drug misuse;Handelsman;Med J Aust,2013

2. Testosterone prescribing in the United States, 2002–2016;Baillargeon;JAMA,2018

3. Ascertainment of testosterone prescribing practices in the VA;Jasuja;Med Care,2015

4. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline;Bhasin;J Clin Endocrinol Metab,2010

5. Efficacy and safety of testosterone treatment in men: an evidence report for a clinical practice guideline by the American College of Physicians;Diem;Ann Intern Med,2020

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular disease and testosterone therapy in male hypogonadism;Annals of the New York Academy of Sciences;2024-09-07

2. Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

3. Metabolic and cardiovascular risks of hormone treatment for transgender individuals;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

4. Evaluating the impact of testosterone replacement therapy on carotid atherosclerosis: a systematic review and meta-analysis;Future Science OA;2024-08-25

5. Male hypogonadism: pathogenesis, diagnosis, and management;The Lancet Diabetes & Endocrinology;2024-08